We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 41-60 of 10,000 results
  1. ESRP1-mediated biogenesis of circPTPN12 inhibits hepatocellular carcinoma progression by PDLIM2/ NF-κB pathway

    Background

    Emerging evidence indicates the pivotal involvement of circular RNAs (circRNAs) in cancer initiation and progression. Understanding the...

    Yang Ji, Chuangye Ni, ... Xuehao Wang in Molecular Cancer
    Article Open access 11 July 2024
  2. N6-methyladenosine modification of circMARK2 enhances cytoplasmic export and stabilizes LIN28B, contributing to the progression of Wilms tumor

    Background

    The potential involvement of circular RNAs (circRNAs) and N 6 -methyladenosine (m 6 A) modification in the progression of Wilms tumor (WT) has...

    Guannan Shu, Zhang Zhao, ... Guochang Liu in Journal of Experimental & Clinical Cancer Research
    Article Open access 11 July 2024
  3. Lipidome changes due to improved dietary fat quality inform cardiometabolic risk reduction and precision nutrition

    Current cardiometabolic disease prevention guidelines recommend increasing dietary unsaturated fat intake while reducing saturated fats. Here we use...

    Fabian Eichelmann, Marcela Prada, ... Clemens Wittenbecher in Nature Medicine
    Article Open access 11 July 2024
  4. A global initiative to deliver precision health in diabetes

    W. T. Cefalu, P. W. Franks, ... S. S. Rich in Nature Medicine
    Article 11 July 2024
  5. Benmelstobart, anlotinib and chemotherapy in extensive-stage small-cell lung cancer: a randomized phase 3 trial

    Immunochemotherapy is the first-line standard for extensive-stage small-cell lung cancer (ES-SCLC). Combining the regimen with anti-angiogenesis may...

    Ying Cheng, Jianhua Chen, ... Runxiang Yang in Nature Medicine
    Article Open access 11 July 2024
  6. Adoptive transfer of personalized neoantigen-reactive TCR-transduced T cells in metastatic colorectal cancer: phase 2 trial interim results

    Adoptive cell transfer (ACT) with neoantigen-reactive T lymphocytes can mediate cancer regression. Here we isolated unique, personalized,...

    Maria Parkhurst, Stephanie L. Goff, ... Steven A. Rosenberg in Nature Medicine
    Article 11 July 2024
  7. Impact of baseline body composition on prognostic outcomes in urological malignancies treated with immunotherapy: a pooled analysis of 10 retrospective studies

    Objective

    Numerous epidemiological investigations have explored the impact of body composition on the effectiveness of immune checkpoint inhibitors...

    Wangbin Ma, Qiao Shi, ... ZK in BMC Cancer
    Article Open access 11 July 2024
  8. Characterization of a missense variant in COG5 in a Tunisian patient with COG5-CDG syndrome and insights into the effect of non-synonymous variants on COG5 protein

    The clinical diagnosis of patients with multisystem involvement including a pronounced neurologic damage is challenging. High-throughput sequencing...

    Boudour Khabou, Umar Bin Mohamad Sahari, ... Chahnez Charfi Triki in Journal of Human Genetics
    Article 11 July 2024
  9. Survival of advanced/recurrent gastrointestinal stromal tumors treated with tyrosine kinase inhibitors in Taiwan: a nationwide registry study

    Background

    Most gastrointestinal stromal tumors (GISTs) harbor c-KIT or PDGFRA mutations. Administration of tyrosine kinase inhibitors (TKIs) has...

    Hui-Jen Tsai, Yan-Shen Shan, ... Tsang-En Wang in BMC Cancer
    Article Open access 11 July 2024
  10. The relationship between Stroma AReactive Invasion Front Areas (SARIFA), Warburg-subtype and survival: results from a large prospective series of colorectal cancer patients

    Background

    Stroma AReactive Invasion Front Areas (SARIFA) is a recently identified haematoxylin & eosin (H&E)based histopathologic biomarker in...

    Kelly Offermans, Nic G. Reitsam, ... Piet A. van den Brandt in Cancer & Metabolism
    Article Open access 11 July 2024
  11. A new approach to prevent radiation-induced xerostomia using intraglandular injection of mitochondria-boosting agents

    Radiotherapy in patients with head and neck cancer fairly leads to xerostomia, profoundly affecting their quality of life. With limited effective...

    Mohammad Farhadi, Pedram Fadavi, ... Farzad Taghizadeh-Hesary in BMC Cancer
    Article Open access 11 July 2024
  12. Circ_0000069 promotes the development of hepatocellular carcinoma by regulating CCL25

    Background

    Hepatocellular carcinoma (HCC) is a leading cause of cancer-related deaths globally, influenced by aberrant circRNA expression....

    Junshao Zeng, Yi Feng, ... Yifan Sun in BMC Cancer
    Article Open access 11 July 2024
  13. Understanding the experience, treatment preferences and goals of people living with chronic lymphocytic leukemia (CLL) in Australia

    Background

    Listening to patient voices is critical, in terms of how people experience their condition as well as their treatment preferences. This...

    Simon Fifer, Jenni Godsell, ... Marija McGeachie in BMC Cancer
    Article Open access 11 July 2024
  14. Precision public health in the era of genomics and big data

    Precision public health (PPH) considers the interplay between genetics, lifestyle and the environment to improve disease prevention, diagnosis and...

    Megan C. Roberts, Kathryn E. Holt, ... Caitlin G. Allen in Nature Medicine
    Article 11 July 2024
  15. Women’s health is on the ballot in 2024

    Sophie Harman in Nature Medicine
    Article 11 July 2024
  16. Enhancing cancer therapy: the integration of oncolytic virus therapy with diverse treatments

    As one of the significant challenges to human health, cancer has long been a focal point in medical treatment. With ongoing advancements in the field...

    Zhuo Yan, Zhengbo Zhang, ... Zhangquan Wang in Cancer Cell International
    Article Open access 11 July 2024
  17. Combination of dual JAK/HDAC inhibitor with regorafenib synergistically reduces tumor growth, metastasis, and regorafenib-induced toxicity in colorectal cancer

    Background

    Treatment with regorafenib, a multiple-kinase inhibitor, to manage metastatic colorectal cancers (mCRCs) shows a modest improvement in...

    Prachi Bajpai, Sumit Agarwal, ... Upender Manne in Journal of Experimental & Clinical Cancer Research
    Article Open access 11 July 2024
  18. Combinatorial macrophage induced innate immunotherapy against Ewing sarcoma: Turning “Two Keys” simultaneously

    Background

    Macrophages play important roles in phagocytosing tumor cells. However, tumors escape macrophage phagocytosis in part through the...

    Wen Luo, Hai Hoang, ... Mitchell S. Cairo in Journal of Experimental & Clinical Cancer Research
    Article Open access 11 July 2024
Did you find what you were looking for? Share feedback.